Morphine Extended-Release Capsules and Zoladex (Goserelin Implant 10.8 mg)
Determining the interaction of Morphine Extended-Release Capsules and Zoladex (Goserelin Implant 10.8 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Zoladex (Goserelin Implant 3.6 mg)
- Morphine Extended-Release Capsules-Zoladex 3-Month
- Morphine Extended-Release Capsules-Zoladex Implant
- Morphine Extended-Release Capsules-Zolate
- Morphine Extended-Release Capsules-Zoledronic acid
- Morphine Extended-Release Capsules-Zoledronic Acid (Bone Health)
- Zoladex (Goserelin Implant 10.8 mg)-Morphine Immediate-Release Tablets and Capsules
- Zoladex (Goserelin Implant 10.8 mg)-Morphine injection
- Zoladex (Goserelin Implant 10.8 mg)-Morphine Injection PF
- Zoladex (Goserelin Implant 10.8 mg)-Morphine Long-Acting Tablets
- Zoladex (Goserelin Implant 10.8 mg)-Morphine Oral Concentrate (20 mg/mL)
- Zoladex (Goserelin Implant 10.8 mg)-Morphine Oral Solution